The economic consequences of irritable bowel syndrome: a US employer perspective.

Stephanie A. Leong, Victoria Barghout, Howard G. Birnbaum, C Thibeault, Rym Ben-Hamadi, Feride Frech, Joshua J. Ofman

PubMed · 2003 · 152 citations · 17 references

Abstract

Irritable bowel syndrome is a significant financial burden on the employer that arises from an increase in direct and indirect costs compared with the control group.

References

17